Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $41.72B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CORT | CORCEPT THERAPEUTICS INC | $7.90B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NVO | NOVO NORDISK A S | $215.33B | 2.27% | 30.60% | $1.0992 | $1.10 | 49% | 9 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $60.84B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $178.54M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $516.81M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $3.14B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ARGX | ARGENX SE | $56.74B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| LGND | LIGAND PHARMACEUTICALS INC | $3.96B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GMAB | GENMAB A | $19.53B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VCEL | VERICEL CORP | $1.99B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KRYS | KRYSTAL BIOTECH INC | $6.04B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TECH | BIO-TECHNE CORP | $9.13B | 0.55% | 64.00% | $0.0800 | $0.32 | 11% | 1 | 2025-11-28 | |
| RPRX | ROYALTY PHARMA PLC | $22.60B | 2.25% | 49.40% | $0.2200 | $0.88 | 48% | 0 | 2025-12-10 | |
| CRMD | CORMEDIX INC | $786.31M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HALO | HALOZYME THERAPEUTICS INC | $8.30B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MDXG | MIMEDX GROUP INC | $1.05B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GYRE | GYRE THERAPEUTICS INC | $772.59M | N/A | 0.00% | $20.0200 | N/A | N/A | 0 | ||
| VCYT | VERACYTE INC | $3.11B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $10.46B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $110.12B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INCY | INCYTE CORP | $20.45B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ADMA | ADMA BIOLOGICS INC | $3.67B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.96B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INVA | INNOVIVA INC | $1.64B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $2.04B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EXEL | EXELIXIS INC | $11.37B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MNKD | MANNKIND CORP | $1.53B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| REGN | REGENERON PHARMACEUTICALS INC | $74.02B | 0.37% | 6.10% | $0.8800 | $2.64 | 6% | 0 | 2025-11-20 | 2025-12-05 |
| UTHR | UNITED THERAPEUTICS CORP | $20.32B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.77B | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.